|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
13.760 +0.300 (+2.229%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 2.17
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 29.00 RMB (cts) | |
| Net Profit | 733.17 RMB (MIL) | DPS | 16.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 1,218.50 | 48.50 | 20.00 | -- | 1,323.00 | 1,137.00 |
| 2026 | 1,487.00 | 60.25 | 22.00 | -- | 2,819.00 | 1,301.00 |
| 2027 | 1,848.00 | 74.70 | 30.70 | -- | 2,092.00 | 1,568.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 1,244.00 | 50.00 | 28.67 | HUATAI FIN HLDGS HK | Buy | 19.19 | 22/08/2025 | |
| 2025 | 1,137.00 | 45.80 | 13.70 | BOCI | Buy | 16.70 | 25/08/2025 | |
| 2025 | 1,193.00 | 47.70 | -- | BOCOM | Buy | 16.40 | 22/08/2025 | |
| 2025 | 1,251.00 | 51.00 | 24.45 | UBS | Buy | 16.30 | 22/08/2025 | |
| 2025 | 1,182.00 | 48.00 | 20.00 | CICC | OutPerform | 12.80 | 24/06/2025 | |
| 2025 | 1,323.00 | 49.00 | -- | MORGAN STANLEY | Equal-weight | 12.30 | 22/08/2025 | |
| 2026 | 1,476.00 | 60.00 | 33.94 | HUATAI FIN HLDGS HK | -- | -- | 22/08/2025 | |
| 2026 | 1,477.00 | 59.70 | 17.90 | BOCI | -- | -- | 25/08/2025 | |
| 2026 | 1,497.00 | 60.50 | -- | BOCOM | -- | -- | 22/08/2025 | |
| 2026 | 1,608.00 | 65.00 | 32.60 | UBS | -- | -- | 22/08/2025 | |
| 2026 | 1,301.00 | 53.00 | 22.00 | CICC | -- | -- | 24/06/2025 | |
| 2026 | 2,819.00 | 105.00 | -- | MORGAN STANLEY | -- | -- | 22/08/2025 | |
| 2027 | 1,568.00 | 63.00 | 35.99 | HUATAI FIN HLDGS HK | -- | -- | 22/08/2025 | |
| 2027 | 2,092.00 | 84.50 | 25.40 | BOCI | -- | -- | 25/08/2025 | |
| 2027 | 1,848.00 | 74.70 | -- | BOCOM | -- | -- | 22/08/2025 | |
| 2027 | 1,967.00 | 79.00 | 39.58 | UBS | -- | -- | 22/08/2025 | |
| 2027 | 1,818.00 | 68.00 | -- | MORGAN STANLEY | -- | -- | 22/08/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 12/09/2025 11:14 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |